Wegovy in Singapore: What Patients Should Know

Most people who search for this medicine in Singapore are looking for one of two things: what it involves in cost terms, or where to obtain it. This article answers neither directly — because a prescription-only medicine obtained without a prescription is the one route with no assessment, no follow-up and no way to verify what is inside the pen.

What it covers instead is what decides whether treatment works: what semaglutide is, what it is licensed for here, who it suits and who it does not, what supervised care requires, and the questions worth asking before committing to any clinic.

What it is

Wegovy is the brand name for semaglutide, a once-weekly injection that acts on the GLP-1 receptor — one of the gut hormones released after eating that influence fullness, how quickly the stomach empties, insulin release and glucagon production.

It is not a fat burner in any meaningful sense. It changes appetite signalling and glucose handling, and the weight loss that follows comes from eating less, comfortably enough to sustain.

What it is licensed for in Singapore

Semaglutide is registered with the Health Sciences Authority as a prescription-only medicine. The Singapore product information lists these indications for this brand:

1. Weight management in adults — as an adjunct to a reduced-calorie diet and increased physical activity, for weight loss and weight maintenance, in adults with an initial BMI of:
   • 30 kg/m² or above (obesity), or
   • 27 to below 30 kg/m² (overweight) with at least one weight-related condition — for example dysglycaemia (prediabetes or type 2 diabetes), hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease.
2. Cardiovascular risk reduction — to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease who also have obesity or overweight.
3. Adolescents aged 12 and above — weight management for those with obesity and body weight above 60 kg, with discontinuation and re-evaluation if the response is inadequate.

Two practical points follow. First, weight management here is a licensed use, not an off-label one — within the BMI thresholds above, prescribed after assessment. Second, the adolescent indication is a clinical decision that requires careful evaluation, not something to infer from an adult’s experience.

Who it may suit, and who it does not

A doctor assesses this individually, but the shape of the decision is predictable.

It may be reasonable to consider if your BMI sits in the licensed range, previous attempts at diet and activity have not held, and you have weight-related conditions that treatment would help — blood sugar, blood pressure, cholesterol, sleep apnoea, joint pain, fatty liver.

It is generally not the right path if you are pregnant, planning pregnancy or breastfeeding; if you have had a serious allergic reaction to semaglutide; or if you or your family have a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 — both listed as contraindications. A history of pancreatitis, significant gastrointestinal disease or gallbladder problems needs a proper conversation rather than an automatic answer.

That assessment is exactly what an online purchase skips.

What a supervised programme involves

The injection is the easy part. The programme is why the result holds.

1. Assessment. Weight history, previous attempts, other medicines and conditions, blood pressure, and baseline bloods where indicated — kidney and liver function, HbA1c, lipids.

2. A plan you understand. Starting dose, how and when it increases, what the first weeks may feel like, what to do about side effects, and what is being measured besides the scale.

3. Titration with review. The dose rises gradually because tolerance is individual. Reviews are where nausea gets managed, a plateau gets examined, and the plan changes if it should.

4. The maintenance plan. Appetite returns when treatment stops. The exit plan is designed at the start — food, activity, muscle preservation and follow-up — not improvised after the last injection.

Side effects worth knowing about

The common ones are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and early fullness that some people find uncomfortable. They usually settle as the dose stabilises, which is why titration is gradual rather than immediate.

Less common but more serious: pancreatitis, gallbladder problems, and loss of muscle alongside fat when weight comes off quickly. Severe or persistent abdominal pain warrants medical review rather than patience.

Muscle matters more than most people expect. Enough protein and some resistance activity protect the tissue that keeps metabolic rate up — the same tissue crash dieting costs you.

The part nobody advertises

Pens sold through social media, messaging apps or unregistered websites are supplied outside the law. A buyer cannot verify what is in them, how they were stored, or whether the cold chain held. Injectable medicines are not groceries, and there is nobody to screen contraindications, adjust a dose or manage a complication.

The lawful route is unglamorous and it works: a consultation, an assessment, a prescription if appropriate, and review.

Questions worth asking any clinic

• Is weight management a registered indication for the medicine being proposed, in Singapore?
• What are the baseline tests, and what do they involve?
• Who reviews me between visits, and how do I reach them if something goes wrong?
• What is the plan for tapering or stopping, and what happens afterwards?
• What does the whole course involve at each dose, in writing?

Where this fits at Accord Medical

Weight management here is doctor-led and assessment-first: the medical weight loss programme begins with your history and measurements, not with a product. If you are weighing up whether prescription treatment is appropriate, the GLP-1 guide explains how this class of medicine works, the tirzepatide explainer covers the dual-action alternative, and the cost page sets out clinic fees in full.

To talk it through, book a consultation — in clinic or by teleconsult.

---

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for medical concerns, diagnosis, or treatment. Accord Medical Clinic is an MOH-registered medical clinic in Singapore. Dr Joseph Wang (Family Physician) provides medical weight management consultations.

Medicine information referenced from the Singapore National Drug Formulary product information for Wegovy (semaglutide), registration numbers including SIN16704P, SIN16705P, SIN16706P and SIN16745P, last updated October 2026.